Phase II study in children and adults under 40 years with newly diagnosed Langerhans cell histiocytosis: protocol for an LCH-19-MSMFB clinical trial in Japan.

Rintaro Ono Kenichi SakamotoKo KudoAki SatoKazuko KudoHisanori FujinoYuta KawaharaMasahide OkiTakehiko DoiRyu YanagisawaToyotaka KawamataOsamu MiyazakiAtsuko NakazawaYasunori OtaHirokazu KaneganeYozo NakazawaKeizo HoribeAkiko M SaitoAtsushi ManabeKensuke UsukiHitoshi KiyoiAkira MorimotoArinobu TojoYoko Shioda

Published in: BMJ open (2024)

jRCTs041210027.

Keyphrases

phase ii study
newly diagnosed
open label
clinical trial
locally advanced
single cell
phase ii
randomized controlled trial
young adults
cell therapy
study protocol
phase iii
double blind
placebo controlled
radiation therapy
stem cells
squamous cell carcinoma
rectal cancer
mesenchymal stem cells